Emerging modalities, including peptides, oligonucleotides, antibody-drug conjugates or mRNA vaccines, are transforming pharmaceutical manufacturing. Their complexity and the associated high costs and supply chain pressures require rapid technological innovation, both in manufacturing methods and in the integration of digital technologies. This one-day meeting will provide a forum to explore these issues via discussions, knowledge sharing, and networking opportunities, focusing on emerging challenges and research directions.